| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0020600 | Exon-Intron | chr10:31784708-31799347 | chr10:31495779-31510419 | 60 nt | 0.5333 |
| hsa_ZEB1_0020700 | Exon-Exon | chr10:31784708-31799803 | chr10:31495779-31510875 | 321 nt | 0.4393 |
| hsa_ZEB1_0020800 | Exon-Exon | chr10:31784708-31803636 | chr10:31495779-31514708 | 369 nt | 0.4065 |
| hsa_ZEB1_0020400 | Exon-Exon | chr10:31784708-31813041 | chr10:31495779-31524113 | 2523 nt | 0.4241 |
| hsa_ZEB1_0020900 | Exon-Exon | chr10:31784708-31816045 | chr10:31495779-31527117 | 60 nt | 0.5333 |
| hsa_ZEB1_0021000 | Exon-Exon | chr10:31791276-31799803 | chr10:31502348-31510875 | 365 nt | 0.4055 |
| hsa_ZEB1_0021100 | Exon-Exon | chr10:31791276-31803636 | chr10:31502348-31514708 | 471 nt | 0.4013 |
| hsa_ZEB1_0021200 | Exon-Exon | chr10:31791276-31810864 | chr10:31502348-31521936 | 162 nt | 0.4383 |
| hsa_ZEB1_0021300 | Exon-Exon | chr10:31791276-31813041 | chr10:31502348-31524113 | 181 nt | 0.3646 |
| hsa_ZEB1_0021400 | Exon-Exon | chr10:31791380-31813041 | chr10:31502452-31524113 | 2359 nt | 0.4235 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].